Literature DB >> 35096333

Effects of the Long-term Treatment of Proton Pump Inhibitors on the Function of Kidney and Liver in Laboratory Female Rats.

S M J Al-Hadrawy1, Z S Mahdi Al-Turfi2.   

Abstract

Proton pump inhibitors (PPIs) are a group of medications effectively used to inhibit gastric acid secretion and to treat many acid-related disorders, including gastroesophageal reflux disease and other gastric disorders. Recent studies recommended that they may be associated with the risk of chronic kidney disease and liver disease. Therefore, the current study aimed to investigate the effect of long-term treatment with PPIs on kidney and liver function in laboratory rats. Fifteen female albino white rats (Rattusnorvigicus) were randomly assigned to three groups of five animals. The control group was fed regular pellet, group PPI-2 received standard pellet diet and was given esomeprazole (10 mg/kg b.w.) via daily oral gavage in mornings for two weeks, and group PPI-3 was fed standard pellet diet and was given esomeprazole (10 mg/kg b.w.) via daily oral gavage in mornings for three months. Blood samples were taken after 2 weeks and 3 months by cardiac puncture for measuring serum creatinine, urea, total bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP). In addition, kidney and liver tissues were histopathologically evaluated. Serum creatinine, urea, ALT, total bilirubin, and ALP significantly increased in group PPI-3, compared to other groups. Histopathological study of the kidneys and liver revealed normal histology structure in the control group and the rats of the PPI-2 group, while some histological changes were observed in the liver and kidney of the animals in the PPI-3 group. The histological changes included the widening of Bowman's space and shrunken glomeruli, whereas the renal tubules had congested tubular cells. Furthermore, congestion in the blood vessels and hepatic cells degradation were observed in the liver. These data indicate that the long-term administration of PPIs has adverse effects on the structure and function of the kidney and liver.

Entities:  

Keywords:  Esomeprazole; Kidney function; Liver function; Long-term Treatment; Proton pump inhibitor

Mesh:

Substances:

Year:  2021        PMID: 35096333      PMCID: PMC8791006          DOI: 10.22092/ari.2021.355947.1745

Source DB:  PubMed          Journal:  Arch Razi Inst        ISSN: 0365-3439


  29 in total

1.  Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.

Authors:  Benjamin Lazarus; Yuan Chen; Francis P Wilson; Yingying Sang; Alex R Chang; Josef Coresh; Morgan E Grams
Journal:  JAMA Intern Med       Date:  2016-02       Impact factor: 21.873

2.  Changes in prescription patterns of acid-suppressant medications by Belgian pediatricians: analysis of the national database, [1997-2009].

Authors:  Pauline De Bruyne; Thierry Christiaens; Robert Vander Stichele; Myriam Van Winckel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-02       Impact factor: 2.839

Review 3.  Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis.

Authors:  Steven G Coca; Swathi Singanamala; Chirag R Parikh
Journal:  Kidney Int       Date:  2011-11-23       Impact factor: 10.612

4.  Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.

Authors:  Yohannes T Ghebremariam; Paea LePendu; Jerry C Lee; Daniel A Erlanson; Anna Slaviero; Nigam H Shah; James Leiper; John P Cooke
Journal:  Circulation       Date:  2013-07-03       Impact factor: 29.690

5.  Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

Authors:  Sandra Dial; Khalid Alrasadi; Chantal Manoukian; Allen Huang; Dick Menzies
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

Review 6.  Proton pump inhibitors in cirrhosis: tradition or evidence based practice?

Authors:  Francesca Lodato; Francesco Azzaroli; Maria Di Girolamo; Valentina Feletti; Paolo Cecinato; Andrea Lisotti; Davide Festi; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

Review 7.  Perils and pitfalls of long-term effects of proton pump inhibitors.

Authors:  Sheila M Wilhelm; Ryan G Rjater; Pramodini B Kale-Pradhan
Journal:  Expert Rev Clin Pharmacol       Date:  2013-07       Impact factor: 5.045

8.  Omeprazole-induced acute interstitial nephritis: a possible Th1-Th17-mediated injury?

Authors:  Linda Berney-Meyer; Noelyn Hung; Tania Slatter; John Bw Schollum; A Richard Kitching; Robert J Walker
Journal:  Nephrology (Carlton)       Date:  2014-06       Impact factor: 2.506

9.  A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use.

Authors:  Mei-Ling Blank; Lianne Parkin; Charlotte Paul; Peter Herbison
Journal:  Kidney Int       Date:  2014-03-19       Impact factor: 10.612

10.  The role of the microbiome for human health: from basic science to clinical applications.

Authors:  M Hasan Mohajeri; Robert J M Brummer; Robert A Rastall; Rinse K Weersma; Hermie J M Harmsen; Marijke Faas; Manfred Eggersdorfer
Journal:  Eur J Nutr       Date:  2018-05       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.